IL-1β |
Infant’s vein blood serum |
No association with increased risk of abnormal neurological outcome (including IVH) [34] |
Cerebrospinal fluid |
Association with increased risk of PHH, irrespective of coexistence of WMI [28]. Association with increased risk of PHH, but not with WMI [27]. No association with increased risk of abnormal neurological outcome (including IVH) [34] |
IL-6 |
Maternal vein blood serum |
No association with increased risk of IVH [26] |
Umbilical cord blood |
No association with increased risk of IVH [7, 8, 10, 15, 30] |
Infant’s vein blood serum |
Association with increased risk of IVH, its severity, and higher neonatal morbidity [13]. Association with abnormalities in CUS only in infants born after or in week 28 of gestational age [34] |
Cerebrospinal fluid |
Association with increased risk of PHH, but not with WMI [27]. Association with abnormalities in CUS only in infants born before or in week 28 of gestational age [34] |
IL-8 |
Umbilical cord blood |
No association with IVH [15, 26] |
Infant’s vein blood serum |
Association with isolated IVH and both IVH and WMI [18] |
Cerebrospinal fluid |
Association with increased risk of PHH, but not with WMI [27] |
IL-18 |
Cerebrospinal fluid |
Association with posthemorrhagic ventricular dilatation [3] |
TNF-α |
Cerebrospinal fluid |
Association with abnormalities in CUS only in infants born before or in week 28 of gestational age [34]. Association with increased risk of PHH, but not with WMI [27] |